Drugs / PBSC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02240992 | Sep 2014 → Sep 2018 | disease related to hematopoietic stem cell transplant, thrombocytopenia | Nanfang Hospital, Southern Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02240992 ↗ |
| Route | Intravenous | “PBSC will be intravenously infused” NCT02240992 ↗ |